Journal article
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Abstract
Importance: Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment of high-risk outpatients with COVID-19 in developing countries are needed.
Objective: To determine whether hydroxychloroquine or lopinavir-ritonavir reduces hospitalization among high-risk patients with early symptomatic COVID-19 in an outpatient setting.
Authors
Reis G; dos Santos Moreira Silva EA; Silva DCM; Thabane L; Singh G; Park JJH; Forrest JI; Harari O; dos Santos CVQ; de Almeida APFG
Journal
JAMA Network Open, Vol. 4, No. 4,
Publisher
American Medical Association (AMA)
Publication Date
April 1, 2021
DOI
10.1001/jamanetworkopen.2021.6468
ISSN
2574-3805